BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11896977)

  • 21. Aspirin in venous leg ulcer study (ASPiVLU): study protocol for a randomised controlled trial.
    Weller CD; Barker A; Darby I; Haines T; Underwood M; Ward S; Aldons P; Dapiran E; Madan JJ; Loveland P; Sinha S; Vicaretti M; Wolfe R; Woodward M; McNeil J
    Trials; 2016 Apr; 17():192. PubMed ID: 27068695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of aspirin therapy in the ulcer associated with chronic venous insufficiency.
    del Río Solá ML; Antonio J; Fajardo G; Vaquero Puerta C
    Ann Vasc Surg; 2012 Jul; 26(5):620-9. PubMed ID: 22437068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of hyperbaric oxygen therapy for healing chronic venous leg ulcers: A randomized, double-blind, placebo-controlled trial.
    Thistlethwaite KR; Finlayson KJ; Cooper PD; Brown B; Bennett MH; Kay G; O'Reilly MT; Edwards HE
    Wound Repair Regen; 2018 Jul; 26(4):324-331. PubMed ID: 30129080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotics and antiseptics for venous leg ulcers.
    O'Meara S; Al-Kurdi D; Ovington LG
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003557. PubMed ID: 18254024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ; Smiell JM; Su Y
    Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of LL-37 in healing of hard-to-heal venous leg ulcers: A multicentric prospective randomized placebo-controlled clinical trial.
    Mahlapuu M; Sidorowicz A; Mikosinski J; Krzyżanowski M; Orleanski J; Twardowska-Saucha K; Nykaza A; Dyaczynski M; Belz-Lagoda B; Dziwiszek G; Kujawiak M; Karczewski M; Sjöberg F; Grzela T; Wegrzynowski A; Thunarf F; Björk J; Ekblom J; Jawien A; Apelqvist J
    Wound Repair Regen; 2021 Nov; 29(6):938-950. PubMed ID: 34687253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Initial clinical experiences with platelet-derived wound healing factor in venous ulcers].
    Coerper S; Köveker G; Tolksdorf A; Becker HD
    Vasa Suppl; 1992; 35():173. PubMed ID: 1481034
    [No Abstract]   [Full Text] [Related]  

  • 28. Acceleration of wound healing in traumatic ulcers by absorbable collagen sponge containing recombinant basic fibroblast growth factor.
    Yao C; Yao P; Wu H; Zha Z
    Biomed Mater; 2006 Mar; 1(1):33-7. PubMed ID: 18458383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
    Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
    Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose aspirin as an adjuvant treatment for venous leg ulceration: study protocol for a randomized controlled trial (Aspirin4VLU).
    Jull A; Wadham A; Bullen C; Parag V; Kerse N; Waters J
    J Adv Nurs; 2016 Mar; 72(3):669-79. PubMed ID: 26708314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
    Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
    J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant bovine basic fibroblast growth factor accelerates wound healing in patients with burns, donor sites and chronic dermal ulcers.
    Fu X; Shen Z; Chen Y; Xie J; Guo Z; Zhang M; Sheng Z
    Chin Med J (Engl); 2000 Apr; 113(4):367-71. PubMed ID: 11775238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, double-blind, placebo-controlled, dose- ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers.
    Da Costa RM; Ribeiro Jesus FM; Aniceto C; Mendes M
    Wound Repair Regen; 1999; 7(1):17-25. PubMed ID: 10231502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
    Arosio E; Ferrari G; Santoro L; Gianese F; Coccheri S;
    Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):365-72. PubMed ID: 11563899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repifermin. Human Genome Sciences/GlaxoSmithKline.
    Wheeler G
    IDrugs; 2001 Jul; 4(7):813-9. PubMed ID: 15995938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzymatic debridement: is HA-collagenase the right synergy? Randomized double-blind controlled clinical trial in venous leg ulcers.
    Scalise A; Campitiello F; Della Corte A; Longobardi P; Di Salvo M; Tartaglione C; Santin C; Giordan N; Guarnera G
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1421-1431. PubMed ID: 28387882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topically applied recombinant tissue plasminogen activator for the treatment of venous ulcers. Preliminary report.
    Falanga V; Carson P; Greenberg A; Hasan A; Nichols E; McPherson J
    Dermatol Surg; 1996 Jul; 22(7):643-4. PubMed ID: 8680787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymosin beta-4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing.
    Guarnera G; DE Rosa A; Camerini R
    Ann N Y Acad Sci; 2007 Sep; 1112():407-12. PubMed ID: 17495250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.
    Kirsner RS; Marston WA; Snyder RJ; Lee TD; Cargill DI; Slade HB
    Lancet; 2012 Sep; 380(9846):977-85. PubMed ID: 22863328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers - a randomized pilot study.
    Romanelli M; Macchia M; Panduri S; Paggi B; Saponati G; Dini V
    Drug Des Devel Ther; 2015; 9():2787-92. PubMed ID: 26060395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.